Posted on September 6, 2016
CardioDiagnostics is a medical technology company specialized in cardiac care solutions. It was founded by Ziad Sankari in 2012. Ziad lost his father to a heart attack when he was seventeen. He decided to pursue his studies in understanding the electrical activity of the heart and how monitoring and analyzing that activity can save lives. Today, the company uses FDA-approved wearable devices that are 24/7 GPS-enabled heart rate monitors allowing monitoring centers to communicate diagnostic and preventive information to patients in the United States, and globally.
During a program aiming to test its technologies that had been taking place in the last couple of months, CardioDiagnostics conducted tests on volunteer team members. During one of the monitoring periods, and while a team member had CardioDiagnostics device on, a heart abnormality was detected by the device, reflecting a heart rate of 190 bpm. Being fully aware of the medical symptoms, and because the device was providing info urging him to go to the hospital, that team member rushed to the ER where he was diagnosed with Atrial Fibrillation and admitted to ICU. Atrial fibrillation, or AFib, is a heart arrhythmia that occurs when disorganized electrical signals in the heart cause the heart’s upper chambers to contract quickly and irregularly. AFib increases the risk of stroke, and in some people may cause chest pain or heart failure.
In the light of that surprising event, the CardioDiagnostics team members, who are aware of what Atrial Fibrillation can cause and how it can lead to stroke, set out a new goal. In the aim of preventing the development of extreme cases, the team is creating a new technology that will diagnose Atrial Fibrillation early on through everyday wearables, and therefore reduce the number of people who are developing strokes and dying of heart disease.